Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The investigators propose to use clinically validated patient avatar technology ("PDXovo") that can test multiple drugs against patients' cancers to identify the most promising systemic therapy for each individual.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Rak piersi z przerzutami, dowolny typ
- •Widoczne zmiany chorobowe do zmierzenia (wg kryteriów RECIST 1.1)
- •Przerzuty w węzłach chłonnych lub organach wewnętrznych
- •Zgoda na pobranie próbki tkanki przed rozpoczęciem leczenia
✗ Disqualifies
- •Niemożliwość bezpiecznego pobrania próbki z przerzutu (np. ze względu na bliskość naczyń krwionośnych)
- •Brak możliwości wyrażenia świadomej zgody
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- January 20, 2025
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Sunnybrook Health Sciences Centre
Toronto, Canada
Trial contact
Katarzyna J Jerzak, MD MSc FRCPC
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.